Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1441–1464 of 2,913 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Event Clear all

Conditions: Gastric Ulcer
Interventions: PA32540, EC Aspirin 325; Drug
Lead sponsor: POZEN; Industry
Eligibility: 55 Years and older
Enrollment: 530 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Dry Eye Syndrome, Systemic Lupus Erythematosus
Interventions: ABBV-319; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 7
States / cities: Avon Park, Florida • Clearwater, Florida • Margate, Florida + 4 more

Conditions: Urinary Tract Infection
Interventions: Urine Culture, Foley Catheter Tip Culture, Scanning Electron Microscopy, Device Specific Adverse Event Assessment, Foley Catheter Insertion; Biological · Device · Procedure
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 21 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Tampa, Florida • Houston, Texas

Conditions: PTSD - Post Traumatic Stress Disorder, PTSD (Childbirth-Related)
Interventions: Narrative Exposure Therapy (NET); Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Surgical Site Infection
Interventions: 4% Chlorhexidine Gluconate, 2% Mupirocin, Soap Without Antiseptic Properties (Placebo), Placebo Nasal Ointment; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 2,700 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Newport Beach, California • Orange, California • Sacramento, California + 1 more

Conditions: Sickle Cell Disease, Sickle Cell Anemia
Interventions: N-Acetylcysteine; Drug
Lead sponsor: Bloodworks; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Human Immunodeficiency Virus
Interventions: Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC); Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 59 Years · Male only
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Metastatic Prostate Cancer
Interventions: Risedronate, Placebo; Drug
Lead sponsor: Christopher Sweeney, MBBS; Other
Eligibility: 18 Years and older · Male only
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 31
States / cities: La Mesa, California • San Bernardino, California • New Britain, Connecticut + 26 more

Conditions: SARS-CoV-2, COVID-19
Interventions: Not listed
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 6 Months and older
Enrollment: 927,004 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Heart Failure
Interventions: Provider-Based Care Model Arm, mHealth Model Arm; Other · Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 55 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Acute Kidney Injury
Interventions: Level A, Level B, Passive Alert; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 698 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 8
States / cities: Altoona, Pennsylvania • Farrell, Pennsylvania • McKeesport, Pennsylvania + 3 more

Conditions: Desaturation, Bradycardia, Tachycardia, Hypertension, Hypotension
Interventions: Rapid Response Team (NTX wireless monitoring system); Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,303 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Functional Disability, Dementia, Heart Disease, Stroke, Cancer, Bleeding, Depression, Frailty
Interventions: Not listed
Lead sponsor: Anne Murray; Other
Eligibility: 65 Years and older
Enrollment: 19,114 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 22
States / cities: Birmingham, Alabama • Washington D.C., District of Columbia • Atlanta, Georgia + 18 more

Conditions: Traumatic Birth
Interventions: Intravenous (IV) hydrocortisone; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 133 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Sclerotic Graft Versus Host Disease, Imatinib Mesylate
Interventions: Gleevec, STI571(Imatinib Mesylate); Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 4 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Musculoskeletal Pain, Analgesia, Adverse Event
Interventions: Ketorolac Injection 15 mg, Ketorolac Injection 60 mg; Drug
Lead sponsor: William Beaumont Army Medical Center; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: El Paso, Texas

Conditions: PTSD, Post Traumatic Stress Disorder PTSD, PTSD - Post Traumatic Stress Disorder, Post Traumatic Stress Disorder, Post Traumatic Stress Disorders, Post-traumatic Stress Disorder (PTSD), Post-Traumatic Stress Disorder, PTSD
Interventions: non-invasive vagus nerve stimulation; Device
Lead sponsor: Acacia Clinics; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Sunnyvale, California

Conditions: Acute Pain, Surgery
Interventions: NeuroIDgenetix Test Panel; Other
Lead sponsor: AltheaDx; Industry
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Healthy Volunteers
Interventions: Emraclidine; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Grayslake, Illinois

Conditions: Alzheimer Disease, Cognitive Impairment, Mild, Dementia, Mild
Interventions: Smartphone Personal Assistant, Implementation Intention; Behavioral
Lead sponsor: Baylor University; Other
Eligibility: Not listed
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Temple, Texas

Conditions: Chronic Low Back Pain
Interventions: mindfulness training, non-mindfulness training, book-listening; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: La Jolla, California

Conditions: Intervention Group, Comparison Group, Control Group
Interventions: Watching VR video, Reading text; Other
Lead sponsor: Texas Tech University; Other
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Stroke
Interventions: Transcutaneous vagus nerve stimulation; Device
Lead sponsor: Casa Colina Hospital and Centers for Healthcare; Other
Eligibility: 18 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Pomona, California

Conditions: Pharmacogenomic Testing for Medication Management
Interventions: Not listed
Lead sponsor: ClinLogic LLC; Industry
Eligibility: 25 Years and older
Enrollment: 280,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2030
U.S. locations: 1
States / cities: York, Pennsylvania

Search by objective public record fields.

A Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Efficacy of Micro-Patterned Foley Catheter to Reduce Catheter-Associated Urinary Tract Infection

The New Empowerment After eXposure to Trauma (NEXT) Study

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease

Biomarkers for Event-driven PrEP Adherence

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Innovative Care of Older Adults With Chronic Heart Failure: A Comparative Effectiveness Clinical Trial (I-COACH)

Multi-hospital Electronic Decision Support for Drug-associated Acute Kidney Injury

Validation of the NTX Wireless Patient Monitoring System

Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

Glucocorticoid Administration After Traumatic Birth

Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease

Intramuscular Ketorolac at Two Single-Dose Regimens

Non-invasive Vagus Nerve Stimulation (nVNS) for Post-Traumatic Stress Disorder (PTSD)

Prospective Observational Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Patients Undergoing Elective Surgical Procedures

Study to Assess Adverse Events and How Oral Emraclidine Moves Through the Body of Adult Healthy Volunteers

Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease

Mindfulness and Chronic Low Back Pain

Effects of Semantically Irrelevant Virtual Reality Experience on Memory and Emotion

EEG Changes and DNA Markers Related to taVNS in Stroke Patients: a Preliminary Study

Reduction of Adverse Drug Events and Readmissions